Geno10X BiosciencesA member of GBM Health Group

About Geno10X

Engineering a disciplined path from molecular signal to research insight.

Geno10X Biosciences is the research, AI and technology-translation business within GBM Health Group. It develops a connected molecular-intelligence platform for early cancer and disease research.

01

Mission

Connect RNA science, ultrasensitive molecular detection, rapid sensing, analytical modelling and software so that promising signals can move through a reproducible research path.

02

Relationship to GBM Health Group

Geno10X contributes research and technology translation to a broader health-business portfolio. The relationship supports pathways between scientific work, responsible development and future real-world applications while preserving the distinct role of this research-stage business.

03

Research scope

The public HPV collaboration is one flagship program, not the limit of the platform. The broader direction includes early oncology detection and other disease-research programs that will be described only when suitable public information exists.

RESEARCH_STANDARD

Responsible research principles

  1. 01

    Keep published findings attached to their original methods and authors.

  2. 02

    Advance sensitivity together with specificity, reproducibility and controls.

  3. 03

    Make algorithms traceable to defined measurements and study questions.

  4. 04

    Separate research evidence from clinical, regulatory and commercial readiness.

  5. 05

    Publish new program descriptions only when their scope can be stated accurately.